Cancer Research Compounds

Browse QuantiMol's comprehensive range of cancer research compounds for oncology, cell signalling, apoptosis, cell cycle regulation, DNA damage and repair, angiogenesis, and tumour biology studies. This collection includes anticancer research molecules, kinase inhibitors, epigenetic modulators, PARP inhibitors, HDAC inhibitors, PROTAC degraders, and pathway-specific tool compounds targeting key oncogenic drivers such as PI3K, AKT, mTOR, MAPK, JAK/STAT, EGFR, VEGFR, and BRAF.

Every compound in this collection is supplied by QuantiMol to the highest purity standards, supporting reproducible in vitro and in vivo cancer biology research. Whether you are investigating apoptosis, ferroptosis, autophagy, or metastatic signalling cascades, QuantiMol provides the chemically defined, well-characterised tool compounds needed to drive your oncology research forward with confidence.